Hexagon Nutrition Limited has submitted a regulatory filing pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The disclosure intimates the resignation of two directors from the company's Board of Directors.

Key Quantitative Figures

  • Director Identification Number (DIN) of Mr. Subhash Purushottam Kelkar: 00177280
  • Director Identification Number (DIN) of Mr. Aditya Kelkar: 02312705

Dates of Action

  • The effective date of resignation for both directors is 06 July 2026.
  • The intimation letter to the exchanges is dated 07 July 2026.
  • A referenced SEBI Master Circular is dated 30 January 2026 (Circular no. HO/49/14/14(7)2025 CFDPOD2//3762/2026).
  • A referenced Non-Compete Agreement is dated 20 April 2026.

Parties Involved

  • Resigning Directors: Mr. Subhash Purushottam Kelkar (Executive Director) and Mr. Aditya Kelkar (Non-Executive Director).
  • Regulators: BSE Limited, National Stock Exchange of India Limited (NSE), SEBI.
  • Company Officer: Vedanti Vartak, ACS41580, Company Secretary and Compliance Officer, who signed the submission.

Purpose or Stated Rationale

The reason for both resignations is explicitly stated as being "consequent to their complete divestment of shareholding in the Company" following the company's "recently concluded IPO." Both directors confirm they no longer hold any shares and have fully exited from the company.

Financial or Operational Impact

The disclosure states a governance impact (change in board composition) but does not quantify any direct financial impact on the company. The event is linked to the broader operational event of the recent IPO and the divestment of shares by the directors.

Capital Structure Impact

The resignations are a direct result of a change in ownership (complete divestment of shares by the directors). The disclosure confirms a change in promoter/promoter group holding but does not provide specific pre or post-transaction shareholding percentages.

Additional Commitments

Both resigning directors have confirmed in their individual resignation letters that they "shall continue to be bound by and comply with the terms and conditions of the Non-Compete Agreement dated 20th April 2026." This agreement includes provisions related to confidentiality, non-compete, and non-solicitation obligations for an agreed duration.